Skip to main navigation Skip to search Skip to main content

Rapid identification of international multidrug-resistant Pseudomonas aeruginosa clones by multiple-locus variable number of tandem repeats analysis and investigation of their susceptibility to lytic bacteriophages

  • Jérôme Larché
  • , Flavie Pouillot
  • , Christiane Essoh
  • , Balázs Libisch
  • , Monica Straut
  • , Je Chul Lee
  • , Charles Soler
  • , Richard Lamarca
  • , Elodie Gleize
  • , Jér̂ome Gabard
  • , Gilles Vergnaud
  • , Christine Pourcel
  • PHAGESPOIRS
  • Pherecydes Pharma
  • Université Paris-Saclay
  • CNRS
  • Hungarian National Center for Epidemiology
  • National Institute for Research in Microbiology and Immunology
  • Hôpital d'instruction des armées Percy
  • Centre hospitalier de Narbonne
  • DGA/MRIS- Mission pour la Recherche et l'Innovation Scientifique

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

The objective of this study was to determine the genetic diversity of multidrug-resistant (MDR) Pseudomonas aeruginosa strains isolated over a period of 12 months in two French hospitals and to test their susceptibility to bacteriophages. A total of 47 MDR isolates recovered from hospitalized patients were genotyped using multiple-locus variable number of tandem repeats analysis. The genotypes were distributed into five clones (including 19, 5, 5, 3, and 3 isolates, respectively) and 12 singletons. Comparison to 77 MDR strains from three other countries, and MLST analysis of selected isolates showed the predominance of international MDR clones. The larger clone, CC235, contained 59 isolates displaying different antibiotic resistance mechanisms, including the presence of the GES1, VIM-2, VIM-4, and IMP-1 β-lactamases. Three newly isolated P. aeruginosa bacteriophages were found to lyse 42 of the 44 analyzed strains, distributed into the different clonal complexes. This pilot study suggests that systematic genotyping of P. aeruginosa MDR strains could improve our epidemiological understanding of transmission at both the local (hospital) and the national level and that phage therapy could be an alternative or a complementary treatment to antibiotics for treating MDR-infected patients.

Original languageEnglish
Pages (from-to)6175-6180
Number of pages6
JournalAntimicrobial Agents and Chemotherapy
Volume56
Issue number12
DOIs
StatePublished - Dec 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Rapid identification of international multidrug-resistant Pseudomonas aeruginosa clones by multiple-locus variable number of tandem repeats analysis and investigation of their susceptibility to lytic bacteriophages'. Together they form a unique fingerprint.

Cite this